Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

MLA

Bhatt, Vijaya R., et al. “Clinicopathologic Features, Management and Outcomes of Blastoid Variant of Mantle Cell Lymphoma: A Nebraska Lymphoma Study Group Experience.” Leukemia & Lymphoma, vol. 57, no. 6, June 2016, pp. 1327–34. EBSCOhost, https://doi.org/10.3109/10428194.2015.1094801.

APA

Bhatt, V. R., Loberiza, F. R., Smith, L. M., Armitage, J. O., Greiner, T. C., Bast, M., Lunning, M. A., Bierman, P. J., Vose, J. M., & Bociek, R. G. (2016). Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience. Leukemia & Lymphoma, 57(6), 1327–1334. https://doi.org/10.3109/10428194.2015.1094801

Chicago

Bhatt, Vijaya R., Fausto R. Loberiza, Lynette M. Smith, James O. Armitage, Timothy C. Greiner, Martin Bast, Matthew A. Lunning, Philip J. Bierman, Julie M. Vose, and R. Gregory Bociek. 2016. “Clinicopathologic Features, Management and Outcomes of Blastoid Variant of Mantle Cell Lymphoma: A Nebraska Lymphoma Study Group Experience.” Leukemia & Lymphoma 57 (6): 1327–34. doi:10.3109/10428194.2015.1094801.